Skip to main content
SpringerLink
Log in

Anti-staphylococcal potential of Callistemon rigidus

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

The last decade witnessed the emergence of Staphylococcus aureus- a versatile human pathogen, as a deadly superbug. The enormous genetic plasticity of the organism assists it to endlessly evolve resistance mechanisms against existing anti-infectives thus necessitating the need to control the spread of resistant staphylococcal isolates in hospitals and health care settings. This in turn demands the incessant exploration of newer biological matrices in search of diverse chemical entities with novel drug targets. Since time immemorial higher plants continue to be the best source of newer compounds with high therapeutic potential. Lead fractions from same or different plants can be developed into effective antibacterial polyherbal formulations. A lead fraction from methanolic extract of leaves of Callistemon rigidus exhibited a dose dependent antistaphylococcal activity during in vitro agar well assay against a panel of twenty seven clinical multidrug resistant S. aureus isolates. Further, minimal inhibitory concentration (MIC) evaluation by in vitro 96-well microplate based assay established a MIC range of 1.25–80 μg/ml as compared to 5–320 μg/ml of positive control, Cefuroxime sodium. The MIC50 and MIC90 of the methanolic lead fraction were 5 μg/ml and 40 μg/ml respectively. The present study thus signifies the vast potential of the lead fraction from Callistemon rigidus for future development into a herbal drug/ formulation and to impede global health crisis due to multidrug resistant Staphylococcus aureus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G.J. Moran, R.N. Amii, F.M. Abrahamian and D.A. Talan: “Methicillin resistant Staphylococcus aureus in community-acquired skin infections”, Emerg. Infec. Dis., Vol. 11, (2005), pp. 928–930.

    Google Scholar 

  2. Y. Yamazaki, K. Hirai and T. Honda: “Pseudomembranous tracheobronchitis caused by Methicillin resistant Staphylococcus aureus”, Scand. J. Infect. Dis., Vol. 34, (2001), pp. 211–221.

    Article  Google Scholar 

  3. H. Watanabe, L. Masaki, N. Asoh, K. Watanabe, K. Oishi, S. Kobayashi, A. Sato and T. Nagataka: “Molecular analysis of Methicillin resistant Staphylococcus aureus as a causative agent of Bronchopulmonary infection: relation to colonization in upper respiratory tract”, J. Clin. Microbiol., Vol. 38, (2000), pp. 3867–3869.

    PubMed  CAS  Google Scholar 

  4. V.G. Fowler, M.K. Olsen, G.R. Corey, C.W. Woods, C.H. Cabell, H.B. Reller: “Clinical identifiers of complicated Staphylococcus aureus bacteraemia”, Arch. Intern. Med., Vol. 163, (2003), 2066–2072.

    Article  PubMed  Google Scholar 

  5. F. Vandenesch, N. Timothy, M. Enright, G. Lina, G.R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M.E. Reverdy and J. Etienne: “Community acquired Methicillin resistance Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: worldwide emergence”, Emerg. Infect. Diseases., Vol. 9, (2003), pp. 978–984.

    Google Scholar 

  6. F.J. Schmitz, A.D.C. Fluit, M. Gandolf, R. Beyrau, E. Lindenlauf, J. Verhoef and M.E. Jones: “The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of Staphylococci from 19 European hospitals”, J. Antimicrob. Chemother., Vol. 43, (1999), pp. 253–259.

    Article  PubMed  CAS  Google Scholar 

  7. Alghaithy AA, N.E. Bilal, M. Gedebou and A.H. Wiley: “Nasal carriage and antibiotic Staphylococcus aureus isolates from hospital and non-hospital personnel in Abha, Saudi, Arabia. Trans. R. Soc. Trop. Med. Hyg., Vol. 94, (2000), pp. 504–507.

    Article  PubMed  CAS  Google Scholar 

  8. T. Kluytmann, A.V. Belkum and H. Verbrugh: “Nasal carriage of Staphylococcus aureus: epidemiology, mechanisms and associated risks”, Clin. Microbiol. Rev., Vol. 10, (1997), pp. 505–520.

    Google Scholar 

  9. H.K. Tiwari and M.R. Sen: “Emergence of vancomycin resistant Staphylococcus aureus from a tertiary care hospital from northern part of India”, BMC Infec. Dis., Vol. 6, (2006), pp. 156–161.

    Article  CAS  Google Scholar 

  10. S.E. Cosgrove, K.C. Carroll and T.M. Perl: “Staphylococcus aureus with reduced susceptibility to vancomycin”, Clin. Infec. Dis., Vol. 39, (2004), pp. 539–545.

    Article  CAS  Google Scholar 

  11. K. Hiramatsu, N. Aritaka and H. Hanaki: “Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin”, Lancet, Vol. 350, (1997), pp. 1668–1671.

    Article  Google Scholar 

  12. S. Saxena and D. Kumar: “Tailoring biodiversity for the development of new therapeutics”, Nat. Prod. Rad., Vol. 1, (2002), pp. 18–25.

    Google Scholar 

  13. E. Bombardelli: “Approaches to the quality characteristics of medicinal plant derivatives”, Eur. Phytojournal, Vol. 1, (2001), pp. 30–33.

    Google Scholar 

  14. L. Jirovetz, W. Fleischhacker, G. Buchbauer and M.B. Ngassoum: “Analysis of the essential oils of Callistemon rigidus (Myrtaceae) from Cameroon by GC/FID and GC/MS”, Sci. Pharm., Vol. 65, (1997), pp. 315–319.

    CAS  Google Scholar 

  15. S. Saxena and C. Gomber: “Antimicrobial potential of Callistemon rigidus”, Pharm. Biol., Vol. 44, (2006), pp. 194–201.

    Google Scholar 

  16. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disc Susceptibility tests, NCCLS M100-S12, (2002).

  17. C. Perez, M. Paul and P. Bazerque: “Antibiotic assay by agar well diffusion”, Pharm. Biol. Vol. 43, (1990), pp. 67–71.

    Google Scholar 

  18. Eucast definitive Document E.Def.3.1. European Committee for Antimicrobial Susceptibility Testing: “Determination of minimum inhibitory concentrations (MIC’s) of antibacterial agents by agar dilution”, Clin. Microbiol. & Infec., Vol. 6, (2000), pp. 509–515.

    Article  Google Scholar 

  19. J.M. Andrews: “Determination of minimum inhibitory concentrations”, J. Antimicrob. Chemother., Vol. 48(S1), pp. 5–16.

  20. K. Guven, S. Celik and I. Uysal: “Antimicrobial Activity of Centaurea Species”, Pharm. Biol. Vol. 43, (2005), pp. 67–71.

    Google Scholar 

  21. C.V. Nakamura, N.T. Ueda, E. Bando, A.F.N. Melo, D.A.G. Cortez and B.P.D. Filho: “Antibacterial activity of Ocimum gratissimum L. essential oil”, Mem. Inst. Oswaldo Cruz, Vol. 94, (1999), pp. 675–678.

    PubMed  CAS  Google Scholar 

  22. I.K. Sawer, M.I. Berry and J.L. Ford: “The killing effect of cryptolepine on Staphylococcus aureus”, Lett. Appl. Microbiol., Vol. 40, (2005), pp. 24–29.

    Article  PubMed  CAS  Google Scholar 

  23. M. Canales-Martinez, T. Hernandez-Delgado, C. Flores-Ortiz, A. Duran-Dyaz, A.M. Garcya-Bores and G. Avila-Acevedo: “Antimicrobial Activity of Alternanthera caracasana”, Pharm. Biol., Vol. 43, (2005), pp. 305–307.

    Article  CAS  Google Scholar 

  24. C.U. Iroegbu and C.K. Nkere: “Evaluation of the antibacterial properties of Picralima nitida stembark extracts”, Int. J. Mol. Med. Adv. Sci., Vol. 1(2), pp 182–189.

  25. P.S. Negi and G.K. Jayaprakasha: “Antibacterial activity of grapefruit (Citrus paradisi) peel extracts”, Eur. Food Res. Tech., Vol. 213, (2001), pp. 481–487.

    Google Scholar 

  26. S.V. Reddy, P.V. Srinivas, B. Praveen, K.H. Kishore, B.C. Raju, U.S. Murthy and J.M. Rao: “Antibacterial constituents from the berries of Piper nigrum”, Phytomed., Vol. 11, (2004), pp. 697–700.

    Article  CAS  Google Scholar 

  27. U. Ajali and B.K.C. Chukwurah: “Antimicrobial activity of Securidaca longipenduculata”, Phytomed., Vol. 11, (2004), pp. 701–703.

    Article  CAS  Google Scholar 

  28. S. Mansouri, A. Foroumadi, T. Ghaneie and A.G. Najar: “Antibacterial activity of crude extracts and fractionated constituents of Myrtus communis”, Pharm. Biol., Vol. 39, (2001), pp. 399–401.

    Google Scholar 

  29. C.D. Djipa, M. Delmee and J.Q. Leclarcq: “Antimicrobial activity of bark extracts of Piper, Syzygium jambos (L.), Alston (Myrtaceae)”, J. Ethnopharmacol., Vol. 71, (2001), pp. 303–307.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology & Environmental Sciences, Thapar Institute of Engineering & Technology, Deemed University, Patiala, Punjab, 147004, India

    Charu Gomber & Sanjai Saxena

Authors
  1. Charu Gomber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjai Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjai Saxena.

About this article

Cite this article

Gomber, C., Saxena, S. Anti-staphylococcal potential of Callistemon rigidus . cent.eur.j.med 2, 79–88 (2007). https://doi.org/10.2478/s11536-007-0004-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-007-0004-8

Keywords

Search

Navigation